To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
AMCP Letter to Congress on Final Opioid Conference Report
AMCP sends letter to Congressional Leadership asking for the inclusion of 42 CFR Part 2 provisions and Medicare Fraud Waste and Abuse protections in a final opioid conference report.
Related
To discuss managed care approaches to bsAbs with a focus on FL and DLBCL, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2025.
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - November 2025 Issue
Featured News & Resources
See Full Calendar
Webinars
AMCP eLearning Day: Nexus Encore
National Meetings
AMCP 2026 Registration Opens
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
